2¿ù 25ÀÏ(±Ý) |
|
~14:00 |
°³È¸¼±¾ð |
Local Organizing Committee (´ëȸÀå):
¿ï»êÀÇ´ë ¿Ü°ú È«¼®ÁØ |
|
14:00-15:30 |
Symposium A: Thyroid and Metabolic Syndromes |
ÁÂÀå: ¼º±Õ°üÀÇ´ë ³»°ú ±è±¤¿ø |
|
Regulation of Whole Body Energy Metabolism and Role of Thyroid Hormone |
¿ï»êÀÇ´ë ³»°ú ±è¹Î¼± |
|
Relationship between Thyroid Status and Metabolic Syndrome |
¼¿ïÀÇ´ë ³»°ú ¹Ú¿µÁÖ |
|
Thyroid Cancer and Obesity/Insulin Resistance |
Ãæ³²ÀÇ´ë ³»°ú Á¶¿µ¼® |
|
14:00-15:30 |
Symposium B: Poorly and Undifferentiated thyroid cancer |
ÁÂÀå: ¾ÆÁÖÀÇ´ë ¿Ü°ú ¼ÒÀÇ¿µ |
|
Cytology and Pathology of Poorly and Undifferentiated Thyroid Cancer |
¿¬¼¼ÀÇ´ë º´¸®°ú È«¼ø¿ø |
|
Current Status of Poorly Differentiated Thyroid Cancer in Korea |
¿ï»êÀÇ´ë ³»°ú ±èÅ¿ë |
|
What is debating in Poorly and Undifferentiated Thyroid Cancer |
¾ÆÁÖÀÇ´ë ¿Ü°ú ¼ÒÀÇ¿µ |
|
15:30-15:50 |
Coffee break |
|
15:50-16:50 |
Special Lecture |
ÁÂÀå (ÇÐȸÀå): °¡Å縯ÀÇ´ë ³»°ú À̱¤¿ì |
|
Current and Future Approach to Patients with Advanced Thyroid Cancer |
Univ. of Colorado, Denver, Bryan R. Haugen |
16:50-18:20 |
¿¬±¸ À§¿øȸ Seminar |
|
|
Special Issues with Clinical Research |
ÁÂÀå: ¼º±Õ°üÀÇ´ë À̺ñÀÎÈÄ°ú ¼Õ¿µÀÍ |
|
1. Sample Size & Power Calculation |
°¡Å縯ÀÇ´ë ¿¹¹æÀÇÇаú ÀÓÇö¿ì |
|
2. Analysis of Continuous & Dichotomous Outcomes |
°í·ÁÀÇ´ë ÀÇÇÐÅë°èÇб³½Ç ¾ÈÇüÁø |
|
3. Survival Analysis |
¿ï»êÀÇ´ë ¿¹¹æÀÇÇб³½Ç/ÀÇÇÐÅë°èÇб³½Ç À̹«¼Û |
|
4. How to Interpret Numbers (P-Value & Confidence Interval) |
¼º±Õ°üÀÇ´ë »çȸÀÇÇб³½Ç ½Å¸íÈñ |
|
Dinner Symposium : Advances in Management of Thyroid Cancer (ÁÂÀå : ¼º±Õ°üÀÇ´ë ³»°ú Á¤ÀçÈÆ)
|
ÀϽÃ: 2011³â 2¿ù 25ÀÏ (±Ý) 19:00~21:00 PM / Àå¼Ò: ¼ÛÆı¸ ¹æÀ̵¿ ¿Ã¸²ÇÈÆÄÅ©ÅÚ È£ÅÚ 2Ãþ ¼¿ïȦ |
19:00-21:00 |
1. How Recombinant Human TSH has Changed Our Approach to Thyroid Cancer |
Univ. of Colorado, Denver, Bryan R. Haugen |
|
2. ¹æ»ç¼º ¿ä¿Àµå Ä¡·á/Áø´Ü ½ºÄµ °Ë»ç½ÃÀÇ °©»ó¼±±â´ÉÀúÇÏÁõ (°¡Äª) |
°¡Å縯ÀÇ´ë ³»°ú ÀÓµ¿ÁØ |